Sunshine Biopharma, Inc.
General ticker "SBFM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.3M (TTM average)
Sunshine Biopharma, Inc. follows the US Stock Market performance with the rate: 7.7%.
Estimated limits based on current volatility of 2.5%: low 1.42$, high 1.50$
Factors to consider:
- Total employees count: 44 (-4.3%) as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Lack of profitability, Supply chain disruptions, Customer dependency, Funding requirements, Product liability
Short-term SBFM quotes
Long-term SBFM plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $34.87MM |
| Operating Expenses | $40.69MM |
| Operating Income | $-5.81MM |
| Non-Operating Income | $0.44MM |
| Interest Expense | $0.01MM |
| R&D Expense | $0.93MM |
| Income(Loss) | $-5.37MM |
| Taxes | $-0.23MM |
| Profit(Loss)* | $-5.13MM |
| Stockholders Equity | $23.50MM |
| Inventory | $11.28MM |
| Assets | $30.56MM |
| Operating Cash Flow | $-12.53MM |
| Capital expenditure | $2.32MM |
| Investing Cash Flow | $-2.32MM |
| Financing Cash Flow | $9.29MM |
| Earnings Per Share** | $-7.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.